531015
VENMAX
Start SIP
Invest Now
Start SIP in VENMAX
Performance
- Low
- ₹25
- High
- ₹28
- 52 Week Low
- ₹18
- 52 Week High
- ₹37
- Open Price₹28
- Previous Close₹27
- Volume1,932
Investment Returns
- Over 1 Month -2.21%
- Over 3 Month + 40.28%
- Over 6 Month + 10.8%
- Over 1 Year + 34.41%
Smart Investing Starts Here Start SIP with Venmax Drugs & Pharmaceuticals for Steady Growth!
Venmax Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 41
- PEG Ratio
- 0.2
- Market Cap Cr
- 14
- P/B Ratio
- 2.4
- Average True Range
- 2.05
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.49
- RSI
- 48.96
- MFI
- 56.59
Venmax Drugs & Pharmaceuticals Financials
Venmax Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹26.99
+
0.24
(0.9%)
- Bearish Moving Average 4
- Bullish Moving Average 12
- 20 Day
- ₹26.71
- 50 Day
- ₹27.10
- 100 Day
- ₹26.83
- 200 Day
- ₹24.95
Resistance and Support
26.05
- R3 30.21
- R2 28.59
- R1 27.67
- S1 25.13
- S2 23.51
- S3 22.59
Venmax Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results | |
| 2025-09-02 | Amalgamation & A.G.M. | |
| 2025-08-16 | Others | Inter alia, to consider and approve 1. Allotment of Equity Shares pursuant to conversion of Convertible Equity Share Warrants. |
| 2025-07-23 | Quarterly Results | |
| 2025-05-09 | Audited Results |
Venmax Drugs & Pharmaceuticals F&O
About Venmax Drugs & Pharmaceuticals
- NSE Symbol
- VENMAX
- BSE Symbol
- 531015
- ISIN
- INE154G01022
Similar Stocks to Venmax Drugs & Pharmaceuticals
Venmax Drugs & Pharmaceuticals FAQs
Venmax Drugs & Pharmaceuticals share price is ₹26 As on 07 January, 2026 | 13:20
The Market Cap of Venmax Drugs & Pharmaceuticals is ₹14.1 Cr As on 07 January, 2026 | 13:20
The P/E ratio of Venmax Drugs & Pharmaceuticals is 41 As on 07 January, 2026 | 13:20
The PB ratio of Venmax Drugs & Pharmaceuticals is 2.4 As on 07 January, 2026 | 13:20
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.